NeuroPace Inc — Director's Dealing 2021

Apr 26, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NeuroPace Inc (NPCE)
CIK: 0001528287
Period of Report: 2021-04-26

Reporting Person: Favet Michael (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-04-26	Common Stock	C	7562	$0.00	Acquired	7562	Indirect
2021-04-26	Common Stock	A	15385	$0.03	Acquired	22947	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-04-26	Series A' Preferred Stock	$0.00	C	343	Disposed		Common Stock (343)	Indirect
2021-04-26	Series B' Preferred Stock	$0.00	C	7219	Disposed		Common Stock (7219)	Indirect

Footnotes

F1: Shares are held by the Favet Living Trust, of which the Reporting Person and the Reporting Person's spouse serve as co-trustees.

F2: Each share of Preferred Stock automatically converted on a 1-for-1 basis into Common Stock at any time upon the closing of the Issuer's initial public offering, for no additional consideration. The Preferred Stock has no expiration date.